glp 1 adoption New Demand in an Old Market GLP-1 Receptor Agonist Market Size

Troubleshooting dose related challenges Even with perfect adherence to standard dose charts, challenges emerge that require systematic troubleshooting

doi: 10.1210/en.2018-00399

Some are daily injections (like Saxenda), while others are weekly (like Wegovy and Ozempic)

placebo based on their pre-existing level of DR

Cognitive disorders Pre-clinical and mechanistic studies Our search retrieved a high number ( N = 189) of pre-clinical or mechanistic studies assessing the possible effects of GLP-1RAs on cognitive disorders, which cannot be described in the main text of this article due to space constraints (Supplementary Section 4)

Short-acting but not long-acting glucagon-like protein-1 receptor agonists are associated with increased development of GERD and Barretts esophagus: results from a global healthcare database